GlassScriptPhysician profile
Sandra Vega
NPI 1760454979
$2,622.97
in general payments reported to CMS, 2019-2025
11 companies · $297 in 2025
The $297 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $81.17 · 2021: $45.23 · 2022: $1,974 · 2023: $31.08 · 2024: $21.87 · 2025: $297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $350.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,963.16 | 2022-2023 | Da Vinci Surgical System |
| Hologic Sales and Service, LLC | $353.82 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System, Myosure Tissue Removal Device |
| Pfizer INC. | $70.41 | 2019-2020 | |
| Boston Scientific Corporation | $67.44 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $49.66 | 2019-2020 | |
| Conmed Corporation | $29.41 | 2022 | |
| Daiichi Sankyo INC. | $24.91 | 2019 | |
| Astellas Pharma US INC | $24.44 | 2025 | Veozah |
| Abbvie INC. | $16.20 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.39 | 2022 | |
| Coopersurgical, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Vega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.